Pigmented dermatofibrosarcoma protuberans

Summary

Pigmented dermatofibrosarcoma protuberans (MONDO:0023273) is a disease. A subtype of dermatofibrosarcoma protuberans — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	pigmented dermatofibrosarcoma protuberans
Mondo ID	MONDO:0023273
NCIT	C9430
SNOMED CT	398670003
UMLS	C0334464
MedGen	90786
GARD	0009624
Is cancer (heuristic)	no

Also known as: Bednar Tumor · bednar tumor · Bednar Tumour · bednar tumour · Bednar’s Tumor · Bednar’s Tumour · Bednars Tumor · Bednars Tumour · Dermatofibrosarcoma Protuberan, Pigmented · Dermatofibrosarcoma Protuberans, Pigmented · DFSP, Pigmented · DFSPs, Pigmented · Pigmented dermatofibrosarcoma · Pigmented Dermatofibrosarcoma Protuberan · pigmented dermatofibrosarcoma protuberans · pigmented dermatofibrosarcoma protuberans (bednar tumor) · Pigmented dermatofibrosarcoma protuberans of skin · Pigmented DFSP · Pigmented DFSPs · Pigmented storiform neurofibroma (+4 more)

Disease family

This is a subtype of dermatofibrosarcoma protuberans. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › integumentary system disorder › integumentary system cancer › dermatofibrosarcoma protuberans › pigmented dermatofibrosarcoma protuberans

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.